Bal Pharma Limited
BALPHARMA.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.49B
Close$
Share Statistics
| Market cap | $1.49 Billion |
|---|---|
| Enterprise Value | $1.49 Billion |
| Dividend Yield | $1.20 (1.29%) |
| Earnings per Share | $3.95 |
| Beta | 0.5 |
| Outstanding Shares | 15,920,872 |
Return
| Return on Equity | 8.76% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 20.5 |
|---|---|
| PEG | 4.46 |
| Price to Sales | 0.44 |
| Price to Book Ratio | 1.82 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | 6.37 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bal Pharma Limited
939 employees
CEO: Shailesh D. Siroya Bal Pharma Ltd. is a holding company, which engages in the research, development, and commercialization of pharmaceutical products. It offers prescription drugs, generic medicines, and over-the-counter products. The company was founded on May 19, 1987 and is headquartered in Bangalore, India.